Sen. Sanders Issues Joint Statement on Indictment of Generic Drug Company Exec Involved in Price-Fixing Scheme
February 08, 2020
February 08, 2020
WASHINGTON, Feb. 8 -- Sen. Bernie Sanders, I-Vermont, issued the following joint statement:
Senate Budget Committee Ranking Member Bernie Sanders (I-Vt.) and Oversight Committee Chairwoman Carolyn B. Maloney (D-N.Y.) issued a statement following an announcement that the Department of Justice brought an indictment against Ara Aprahamian, the former Vice President of Sales and Marketing at Taro Pharmaceuticals, on charges including conspiring to fix generic drug prices and making fal . . .
Senate Budget Committee Ranking Member Bernie Sanders (I-Vt.) and Oversight Committee Chairwoman Carolyn B. Maloney (D-N.Y.) issued a statement following an announcement that the Department of Justice brought an indictment against Ara Aprahamian, the former Vice President of Sales and Marketing at Taro Pharmaceuticals, on charges including conspiring to fix generic drug prices and making fal . . .